UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA OPERATIONS LIMITED, AND
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owner.
`__________________
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`__________________
`
`
`
`PATENT OWNER’S OBJECTIONS TO EVIDENCE SUBMITTED BY
`PETITIONER IN SUPPORT OF REPLY
`
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA OPERATIONS LIMITED, AND
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owner.
`__________________
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`__________________
`
`
`
`PATENT OWNER’S OBJECTIONS TO EVIDENCE SUBMITTED BY
`PETITIONER IN SUPPORT OF REPLY
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`Pursuant to 37 C.F.R. § 42.64, Patent Owners Adapt Pharma Operations
`
`Limited and Opiant Pharmaceuticals, Inc. submit the following objections to the
`
`exhibits submitted by Petitioner Nalox-1 Pharmaceuticals, LLC in support of its
`
`reply filed March 12, 2020.
`
`Exhibit 1201 is or purports to be a Supplemental Declaration of Maureen
`
`Donovan, Ph.D. Patent Owners object to Exhibit 1201 under FRE 401, 402, and
`
`403 as irrelevant. Patent Owners further object to Exhibit 1201 as not responsive
`
`to the arguments and evidence cited in the Patent Owner’s Response and/or an
`
`improper attempt to present new evidence that could have been presented earlier in
`
`violation of, e.g., 37 C.F.R. § 42.23(b), including for example in paragraphs 12–18,
`
`20, 22, 24–25, 28, and 30–31 (including their accompanying footnotes).
`
`Exhibit 1202 is or purports to be a Supplemental Declaration of Günter
`
`Hochhaus, Ph.D. Patent Owners object to Exhibit 1202 under FRE 401, 402, and
`
`403 as irrelevant. Patent Owners further object to Exhibit 1202 as not responsive
`
`to the arguments and evidence cited in the Patent Owner’s Response and/or an
`
`improper attempt to present new evidence that could have been presented earlier in
`
`violation of, e.g., 37 C.F.R. § 42.23(b), including for example in paragraphs 19–25,
`
`29–31, 34–40, and 42–44 (including their accompanying footnotes). In addition,
`
`Patent Owners object under FRE 401, 402, 403, 702 and 703 and 21 C.F.R.
`
`§ 42.65(a)–(b) for failure to disclose the underlying facts and data on which Dr.
`
`2
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`Hochhaus based his “simulations,” “model[s],” and/or “calcula[tions]” or to
`
`provide the required affidavit and information in support thereof, including for
`
`example in paragraphs 19, 31, 34–35, 49, 51, 53–54 (including their accompanying
`
`footnotes). Patent Owners further object under FRE 401, 402, 403, 701, 702, and
`
`703 because Dr. Hochhaus is not qualified to offer opinions about the clinical
`
`practice of administering naloxone to treat opioid overdose and does not have
`
`personal experience doing so, including for example in paragraphs 21–22, 27–28
`
`(including their accompanying footnotes).
`
`Patent Owners object to Exhibit 1203 under FRE 401, 402, 403, and 901 as
`
`irrelevant (including because it is not prior art) and not authenticated. Patent
`
`Owners further object to Exhibit 1203 as not responsive to the arguments and
`
`evidence cited in the Patent Owner’s Response and/or an improper attempt to
`
`present new evidence that could have been presented earlier in violation of, e.g., 37
`
`C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1204 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1204 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`3
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`Patent Owners object to Exhibit 1206 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1206 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1207 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1207 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1208 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1208 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1210 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1210 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`4
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`Patent Owners object to Exhibit 1211 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1211 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1213 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1213 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1214 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1214 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1215 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1215 as not responsive to the arguments and evidence cited in the
`
`5
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1216 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1216 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1217 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1217 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1218 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1218 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1219 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1219 as
`
`6
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1220 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1220 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1221 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1221 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1222 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1222 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`7
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`Patent Owners object to Exhibit 1223 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1223 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1224 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1224 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1225 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1225 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1226 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1226 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`8
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`Patent Owners object to Exhibit 1227 under FRE 106, 401, 402, 403, 801,
`
`802, 805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, not authenticated, and an improper compilation of multiple documents.
`
`Patent Owners further object to Exhibit 1227 as not responsive to the arguments
`
`and evidence cited in the Patent Owner’s Response and/or an improper attempt to
`
`present new evidence that could have been presented earlier in violation of, e.g., 37
`
`C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1228 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1228 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1229 under FRE 401, 402, and 403 as
`
`irrelevant (including because it is not prior art). Patent Owners further object to
`
`Exhibit 1229 as not responsive to the arguments and evidence cited in the Patent
`
`Owner’s Response and/or an improper attempt to present new evidence that could
`
`have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1230 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1230 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`9
`
`
`
`
`attempt to present new evidence that could have been presented earlier in violation
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1231 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1231 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1233 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1233 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1234 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1234 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1235 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1235 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`10
`
`
`
`
`attempt to present new evidence that could have been presented earlier in violation
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1236 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1236 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1237 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1237 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1238 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1238 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1239 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1239 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`11
`
`
`
`
`attempt to present new evidence that could have been presented earlier in violation
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1240 under FRE 401, 402, 403, and 37
`
`C.F.R. § 42.6(c) as irrelevant and because it was not filed with a document citing it
`
`and therefore lacks probative value. Patent Owners further object to Exhibit 1240
`
`as not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1241 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1241 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1242 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1242 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1243 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`12
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1243 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1244 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1244 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1245 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1245 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1246 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1246 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`13
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1247 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1247 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1248 under FRE 106, 401, 402, and 403 as
`
`incomplete and irrelevant. Exhibit 1248 is incomplete because Petitioner did not
`
`submit to the Board a complete set of all exhibits used at Dr. Jones’s deposition.
`
`Patent Owners object to Exhibit 1249 under FRE 106, 401, 402, 403, and
`
`901 as incomplete, irrelevant, and not authenticated. Patent Owners further object
`
`to Exhibit 1249 as not responsive to the arguments and evidence cited in the
`
`Patent Owner’s Response and/or an improper attempt to present new evidence that
`
`could have been presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1250 under FRE 401, 402, 403, 801, 802,
`
`805, and 901 as irrelevant (including because it is not prior art), inadmissible
`
`hearsay, and not authenticated. Patent Owners further object to Exhibit 1250 as
`
`not responsive to the arguments and evidence cited in the Patent Owner’s
`
`14
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`Response and/or an improper attempt to present new evidence that could have been
`
`presented earlier in violation of, e.g., 37 C.F.R. § 42.23(b).
`
`Patent Owners object to Exhibit 1251 under FRE 401, 402, and 403 as
`
`irrelevant. Patent Owners further object to Exhibit 1251 as not responsive to the
`
`arguments and evidence cited in the Patent Owner’s Response and/or an improper
`
`attempt to present new evidence that could have been presented earlier in violation
`
`of, e.g., 37 C.F.R. § 42.23(b).
`
`
`Date: March 19, 2020
`
`
`
`Respectfully submitted,
`
`/Jessamyn S. Berniker/
`
`Jessamyn S. Berniker (Reg. No. 72,328)
`Ana C. Reyes (Admitted Pro Hac Vice)
`David M. Krinsky (Reg. No. 72,339)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`jberniker@wc.com
`areyes@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`
`Counsel for Patent Owner
`Adapt Pharma Operations Limited
`
`
`/Jessica Tyrus Mackay/
`
`Jessica Tyrus Mackay (Reg. No. 64,742)
`Ann K. Kotze (Reg. No. 76,570)
`
`15
`
`
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue, Suite 3900
`Chicago, IL 60611
`(313) 883-8000
`jmackay@greengriffith.com
`akotze@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`
`
`
`
`
`16
`
`
`
`Case IPR2019-00688
`U.S. Patent 9,468,747
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing was served on March 19, 2020, by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`Yelee Y. Kim
`Janine A. Carlan
`Richard Berman
`Bradford Frese
`Christopher Yaen
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20036
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`/Jessamyn S. Berniker/
`
`Jessamyn S. Berniker (Reg. No. 72,328)
`
`
`
`
`
`
`
`
`
`
`
`17
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
